Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and the various forms it comes in to know if it’s worth trying or (retrying).

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer. Martin Dietrich, MD, PhD, a medical oncologist at the Cancer Care Centers ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...